Insmed (INSM) Operating Leases (2019 - 2026)

Insmed's Operating Leases history runs 8 years deep, the most recent figure standing at $9.8 million for Q1 2026.

• In Q1 2026, Operating Leases rose 16.0% year-over-year to $9.8 million; the TTM figure through Mar 2026 stood at $9.8 million (up 16.0% YoY), while the FY2025 annual figure was $12.2 million, up 33.6% from the prior year.
• Operating Leases for Q1 2026 stood at $9.8 million, down from $12.2 million in the prior quarter.
• The five-year high for Operating Leases was $19.9 million in Q1 2022, with the low at $7.6 million in Q3 2025.
• The 5-year median for Operating Leases is $12.2 million (2025), against an average of $12.4 million.
• Peak annual rise in Operating Leases reached 33.6% in 2025, while the deepest fall reached 38.59% in 2025.
• Insmed's Operating Leases stood at $14.9 million in 2022, then dropped by 25.85% to $11.0 million in 2023, then retreated by 17.26% to $9.1 million in 2024, then surged by 33.6% to $12.2 million in 2025, then decreased by 19.2% to $9.8 million in 2026.
• Business Quant data shows INSM's Operating Leases at $9.8 million in Q1 2026, $12.2 million in Q4 2025, and $7.6 million in Q3 2025.